GenMark Files for Public Offering of 4.6M Shares | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics has filed with the US Securities and Exchange Commission to offer 4.6 million shares of common stock.

The Carlsbad, Calif.-based molecular diagnostics developer filed its preliminary prospectus for the offering on Wednesday. It didn't say when it expects the offering to become effective.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.